On average, it takes around 12 years for a new drug to reach the market and for the substance to pass through the various approval stages. In the current year 2022, 1,349 drugs have so far been approved in Germany in accordance with §38/39 AMG. Considering that out of 10,000 substances identified and manufactured, on average only one substance makes it through all the testing phases to approval, the chances of success for a potential active ingredient are not only lengthy, but also rather low.
The drug development process is therefore not only laborious, but also associated with a very uncertain outcome. The use of AI helps to reduce the R&D gap in development as well as facilitate production. Machine-simulated human intelligence makes it possible to solve problems in the development process in an accelerated and targeted manner.
In this context, have you ever heard of the Discovery Engine technology? Learn more about the innovative approach in drug development in our new arcoro SNAPS.